Literature DB >> 9496181

Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee.

J A Dodge1, S Morison, P A Lewis, E C Coles, D Geddes, G Russell, J M Littlewood, M T Scott.   

Abstract

The UK Cystic Fibrosis Survey holds data on all people resident in the UK who were diagnosed as having cystic fibrosis and born either since 1968 or before 1968 and alive in 1977. Thus, incidence may be reported from 1968 and prevalence from 1977. The previous estimates are updated to the end of 1995 from data held in the database on 23 August 1996. The incidence is now calculated as one in 2415 live births. The 1992 mid-year population was 6500 people with 65% aged under 16 years. Births outnumber deaths by 160 per year, which suggests a population of 7750 by the year 2000, with all the increase being in the adult age range. The survival of successive cohorts continues to be better than earlier cohorts, the linear descent of the curves is still evident. The infant mortality rate for cystic fibrosis is now under 20 per thousand per year and early childhood mortality is under five per thousand per year. The crude mortality rate for 1995 was 21 per thousand per year, but the standardised mortality ratio was about 3300.

Entities:  

Mesh:

Year:  1997        PMID: 9496181      PMCID: PMC1717408          DOI: 10.1136/adc.77.6.493

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

1.  The frequency of cystic fibrosis of the panceas in Sweden.

Authors:  P SELANDER
Journal:  Acta Paediatr       Date:  1962-01       Impact factor: 2.299

2.  Cystic fibrosis in the Netherlands.

Authors:  L P Ten Kate
Journal:  Int J Epidemiol       Date:  1977-03       Impact factor: 7.196

3.  Gender gap in cystic fibrosis mortality.

Authors:  M Rosenfeld; R Davis; S FitzSimmons; M Pepe; B Ramsey
Journal:  Am J Epidemiol       Date:  1997-05-01       Impact factor: 4.897

4.  The incidence and genetics of cystic fibrosis.

Authors:  Z Brunecký
Journal:  J Med Genet       Date:  1972-03       Impact factor: 6.318

5.  Cystic fibrosis: current survival and population estimates to the year 2000.

Authors:  J S Elborn; D J Shale; J R Britton
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

6.  Cystic fibrosis in the United Kingdom, 1968-1988: incidence, population and survival.

Authors:  J A Dodge; S Morison; P A Lewis; E C Colest; D Geddes; G Russell; A D Jackson; B Bentley
Journal:  Paediatr Perinat Epidemiol       Date:  1993-04       Impact factor: 3.980

  6 in total
  47 in total

Review 1.  The role of vitamins in cystic fibrosis.

Authors:  S B Carr; J McBratney
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

Review 2.  Women with cystic fibrosis and their potential for reproduction.

Authors:  F P Edenborough
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

3.  Potential benefits of the UK Cystic Fibrosis Database.

Authors:  G Mehta; E J Sims; F Culross; J D McCormick; A Mehta
Journal:  J R Soc Med       Date:  2004       Impact factor: 5.344

Review 4.  Understanding cystic-fibrosis-related diabetes: best thought of as insulin deficiency?

Authors:  Lee Dobson; Christopher D Sheldon; Andrew T Hattersley
Journal:  J R Soc Med       Date:  2004       Impact factor: 5.344

5.  Macrophage migration inhibitory factor enzymatic activity, lung inflammation, and cystic fibrosis.

Authors:  Huzaifa Adamali; Michelle E Armstrong; Anne Marie McLaughlin; Gordon Cooke; Edward McKone; Christine M Costello; Charles G Gallagher; Lin Leng; John A Baugh; Günter Fingerle-Rowson; Richard J Bucala; Paul McLoughlin; Seamas C Donnelly
Journal:  Am J Respir Crit Care Med       Date:  2012-05-16       Impact factor: 21.405

Review 6.  Abdominal manifestations of cystic fibrosis in children.

Authors:  Gulraiz Chaudry; Oscar M Navarro; Daniel S Levine; Kamaldine Oudjhane
Journal:  Pediatr Radiol       Date:  2006-01-04

7.  Inferences for health provision from survival data in cystic fibrosis.

Authors:  P A Lewis
Journal:  Arch Dis Child       Date:  1998-10       Impact factor: 3.791

8.  Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study.

Authors:  R Mahadeva; K Webb; R C Westerbeek; N R Carroll; M E Dodd; D Bilton; D A Lomas
Journal:  BMJ       Date:  1998-06-13

Review 9.  Cystic fibrosis: cost of illness and considerations for the economic evaluation of potential therapies.

Authors:  Christian Krauth; Noushin Jalilvand; Tobias Welte; Reinhard Busse
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

10.  Defining chronic diseases and health conditions in childhood (0-18 years of age): national consensus in the Netherlands.

Authors:  Lidwine B Mokkink; Johanna H van der Lee; Martha A Grootenhuis; Martin Offringa; Hugo S A Heymans
Journal:  Eur J Pediatr       Date:  2008-03-14       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.